0000905148-25-003444.txt : 20250930 0000905148-25-003444.hdr.sgml : 20250930 20250930130822 ACCESSION NUMBER: 0000905148-25-003444 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250930 DATE AS OF CHANGE: 20250930 EFFECTIVENESS DATE: 20250930 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Crossbow Therapeutics, Inc. CENTRAL INDEX KEY: 0001972912 ORGANIZATION NAME: EIN: 873073764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-559257 FILM NUMBER: 251359340 BUSINESS ADDRESS: STREET 1: 1030 MASSACHUSETTS AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 860-501-1600 MAIL ADDRESS: STREET 1: 1030 MASSACHUSETTS AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 D 1 primary_doc.xml X0708 D LIVE 0001972912 Crossbow Therapeutics, Inc. 1030 Massachusetts Ave, Suite 210 Cambridge MA MASSACHUSETTS 02138 860-501-1600 DELAWARE None None Corporation true 2021 Briggs Morrison 1030 Massachusetts Ave, Suite 210 Cambridge MA MASSACHUSETTS 02138 Executive Officer Director Promoter Todd Foley 1030 Massachusetts Ave, Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Alexandra Cantley 1030 Massachusetts Ave, Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Irena Melnikova 1030 Massachusetts Ave, Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Charles Baum 1030 Massachusetts Ave, Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Sakae Asanuma 1030 Massachusetts Ave, Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Alon Lazarus 1030 Massachusetts Ave, Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Dmitri Wiederschain 1030 Massachusetts Ave, Suite 210 Cambridge MA MASSACHUSETTS 02138 Executive Officer Alexander Nolte 1030 Massachusetts Ave, Suite Cambridge MA MASSACHUSETTS 02138 Executive Officer Biotechnology Decline to Disclose 06b false 2025-09-17 true true false 0 80000000 30250000 49750000 false 17 0 0 0 false Crossbow Therapeutics, Inc. Briggs Morrison Briggs Morrison Chief Executive Officer 2025-09-30